Invention Grant
- Patent Title: Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
-
Application No.: US16867475Application Date: 2020-05-05
-
Publication No.: US11407738B2Publication Date: 2022-08-09
- Inventor: Jason Allan Wiles , Avinash S. Phadke , Milind Deshpande , Atul Agarwal , Dawei Chen , Venkat Rao Gadhachanda , Akihiro Hashimoto , Godwin Pais , Qiuping Wang , Xiangzhu Wang , William Greenlee
- Applicant: Achillion Pharmaceuticals, Inc.
- Applicant Address: US PA Blue Bell
- Assignee: Achillion Pharmaceuticals, Inc.
- Current Assignee: Achillion Pharmaceuticals, Inc.
- Current Assignee Address: US PA Blue Bell
- Agency: Clark & Elbing LLP
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D403/04 ; C07D401/14 ; C07D471/04 ; C07D413/14 ; C07F9/6558 ; C07D417/14 ; C07D487/04 ; C07D519/00 ; C07D403/12 ; C07D407/14 ; C07D409/14 ; C07D403/10 ; C07D513/04 ; C07D487/22 ; A61P37/00 ; A61P1/16 ; A61P29/00 ; C07D405/14 ; C07D493/04

Abstract:
Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I″ and I′″ or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
Public/Granted literature
- US20200262818A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS Public/Granted day:2020-08-20
Information query